NTLA - Intellia Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NTLA is currently covered by 20 analysts with an average price target of $35.03. This is a potential upside of $28.37 (425.98%) from yesterday's end of day stock price of $6.66.

Intellia Therapeutics's activity chart (see below) currently has 179 price targets and 191 ratings on display. The stock rating distribution of NTLA is 72.06% BUY and 27.94% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 40.88% with an average time for these price targets to be met of 115.69 days.

Highest price target for NTLA is $73, Lowest price target is $9, average price target is $39.21.

Most recent stock forecast was given by BRIAN CHENG from JPMORGAN on 28-Feb-2025.

Currently out of the existing stock ratings of NTLA, 49 are a BUY (72.06%), 19 are a HOLD (27.94%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$13

$4.93 (61.09%)

$55

1 months 5 days ago
(28-Feb-2025)

0/5 (0%)

$2.14 (19.71%)

Buy

$50

$41.93 (519.58%)

1 months 5 days ago
(28-Feb-2025)

1/4 (25%)

$39.14 (360.41%)

3

Hold

$14

$5.93 (73.48%)

$19

1 months 5 days ago
(28-Feb-2025)

3/7 (42.86%)

$3.14 (28.91%)

20

Buy

$68

$59.93 (742.63%)

1 months 5 days ago
(28-Feb-2025)

3/12 (25%)

$57.14 (526.15%)

68

Hold

$9

$0.93 (11.52%)

$76

1 months 5 days ago
(28-Feb-2025)

1/7 (14.29%)

$-1.86 (-17.13%)

20

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is NTLA (Intellia Therapeutics) average time for price targets to be met?

On average it took 115.69 days on average for the stock forecasts to be realized with a an average price target met ratio 40.88

Which analyst has the current highest performing score on NTLA (Intellia Therapeutics) with a proven track record?

GEULAH LIVSHITS

Which analyst has the most public recommendations on NTLA (Intellia Therapeutics)?

Geulah Livshits works at CHARDAN CAPITAL and has 9 price targets and 11 ratings on NTLA

Which analyst is the currently most bullish on NTLA (Intellia Therapeutics)?

Swapnil Malekar with highest potential upside - $154.93

Which analyst is the currently most reserved on NTLA (Intellia Therapeutics)?

Martin Auster with lowest potential downside - -$7.62

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?